A Study to Evaluate the Analgesic Efficacy and Safety of VM902A in Subjects With Osteoarthritis (OA) of the Knee

NCT02847702 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

75

Enrollment

INDUSTRY

Sponsor class

Stopped Company decision

Conditions

Osteoarthritis Pain of the Knee

Interventions

DRUG: VM902A 200-mg Capsules
DRUG: VM902A 400-mg Capsules
DRUG: Naproxen 500-mg Capsules
DRUG: Placebo

Sponsor

Purdue Pharma LP